Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes
- PMID: 21978891
- DOI: 10.1016/j.biomaterials.2011.09.028
Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes
Abstract
Limitations to adenovirus infectivity can be overcome by association with magnetic nanoparticles and enforced infection by magnetic field influence. Here we examined three core-shell-type iron oxide magnetic nanoparticles differing in their surface coatings, particle sizes and magnetic properties for their ability to enhance the oncolytic potency of adenovirus Ad520 and to stabilize it against the inhibitory effects of serum or a neutralizing antibody. It was found that the physicochemical properties of magnetic nanoparticles are critical determinants of the properties which govern the oncolytic productivities of their complexes with Ad520. Although high serum concentration during infection or a neutralizing antibody had strong inhibitory influence on the uptake or oncolytic productivity of the naked virus, one particle type was identified which conferred high protection against both inhibitory factors while enhancing the oncolytic productivity of the internalized virus. This particle type equipped with a silica coating and adsorbed polyethylenimine, displaying a high magnetic moment and high saturation magnetization, mediated a 50% reduction of tumor growth rate versus control upon intratumoral injection of its complex with Ad520 and magnetic field influence, whereas Ad520 alone was inefficient. The correlations between physical properties of the magnetic particles or virus complexes and oncolytic potency are described herein.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force.Mol Pharm. 2010 Aug 2;7(4):1069-89. doi: 10.1021/mp100123t. Mol Pharm. 2010. PMID: 20550160
-
Using a magnetic field to redirect an oncolytic adenovirus complexed with iron oxide augments gene therapy efficacy.Biomaterials. 2015 Oct;65:163-74. doi: 10.1016/j.biomaterials.2015.07.001. Epub 2015 Jul 2. Biomaterials. 2015. PMID: 26164117
-
A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.Cancer Gene Ther. 2008 Mar;15(3):173-82. doi: 10.1038/sj.cgt.7701105. Epub 2007 Dec 21. Cancer Gene Ther. 2008. PMID: 18157145
-
Oncolytic adenoviruses for the treatment of brain tumors.Curr Opin Mol Ther. 2010 Oct;12(5):530-7. Curr Opin Mol Ther. 2010. PMID: 20886384 Review.
-
[Life cycle of magnetic nanoparticles in the organism].Biol Aujourdhui. 2014;208(2):177-90. doi: 10.1051/jbio/2014021. Epub 2014 Sep 8. Biol Aujourdhui. 2014. PMID: 25190577 Review. French.
Cited by
-
Optimizing adenoviral transduction of endothelial cells under flow conditions.Pharm Res. 2012 May;29(5):1219-31. doi: 10.1007/s11095-011-0631-2. Epub 2011 Dec 30. Pharm Res. 2012. PMID: 22207207
-
Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria.Pharm Res. 2012 May;29(5):1344-65. doi: 10.1007/s11095-011-0661-9. Epub 2012 Jan 6. Pharm Res. 2012. PMID: 22222384
-
Emerging delivery strategy for oncolytic virotherapy.Mol Ther Oncol. 2024 Apr 29;32(2):200809. doi: 10.1016/j.omton.2024.200809. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38845744 Free PMC article. Review.
-
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches.Pharmaceutics. 2022 Aug 29;14(9):1811. doi: 10.3390/pharmaceutics14091811. Pharmaceutics. 2022. PMID: 36145559 Free PMC article. Review.
-
Oncolytic virus therapy in cancer: A current review.World J Virol. 2021 Sep 25;10(5):229-255. doi: 10.5501/wjv.v10.i5.229. World J Virol. 2021. PMID: 34631474 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources